Rabies Control in Wildlife

Rabies

Volumn , Issue , 2003, Pages 445-471

  Johnston, David H ^a   Tinline, Rowland R ^b  

^a Johnston Biotech   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 3843141110     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012379077-4/50016-X     Document Type: Chapter

References (106)

1. Anderson R.M., Jackson H.C., May R.M., Smith M. Population dynamics of fox rabies in Europe. Nature 1981, 289:765-771.
2. Andral L., Joubert L. Epidemiologie et prophylaxie écologues de la rage. Med. Mal. Infect. 1975, 5:183-189.
3. Arellano-Sota C. Biology, ecology and control of the vampire bat. Rev. Infect. Dis. 1988, 10(Suppl. 4):S615-S619.
4. Bachmann P., Bramwell R.N., Fraser S.J., Gilmore D.H., Johnston D.H., Lawson K.F., MacInnes C.D., Matejka F.O., Miles H.E., Pedde M.A., Voigt D.R. Wild carnivore acceptance of baits for delivery of liquid rabies vaccine. J. Wildlife Dis. 1990, 26:486-501.
5. Baer G.M., Abelseth M.K., Debbie J.G. Oral vaccination of foxes against rabies. Am. J. Epidemiol. 1971, 93:487-490.
6. Baer G.M. Oral rabies vaccination: An overview. Rev. Infect. Dis. 1988, 10(Suppl. 4):S644-S648.
7. Bigler L.L., Lein D.H. Wildlife rabies vaccination program-St. Lawrence region. USAHA Conference 2001.
8. Bigler W.J., Hoff G.L., Smith J.S., McLean R.G., Trevino H.A., Ingwersen J. Persistence of rabies antibody in free-ranging raccoons. J. Infect. Dis. 1983, 148:610.
9. Bingham J., Schumacher C.L., Hill F.W., Aubert A. Efficacy of SAG-2 oral rabies vaccine in two species of jackal (Canis adustus and Canis mesomelas). Vaccine 1999, 17:551-558.
10. Black J.G., Lawson K.F. Sylvatic rabies studies in the silver fox (Vulpes vulpes): Susceptibility and immune response. Can. J. Comp. Med. 1970, 34:309-311.
11. Bögel K., Meslin F.-X., Kaplan M. Wildlife Rabies Control: Proceedings of the International WHO Symposium 1990 1992, Wells Medical, Royal Tunbridge Wells, England.
12. Broadfoot J.D., Rosatte R.C., O'Leary D.T. Raccoon and skunk population models for urban disease control planning in Ontario, Canada. Ecol. Appl. 2001, 11:295-303.
13. Brochier B., Aubert M.F., Pastoret P.P., Masson E., Schon J., Lombard M., Chappuis G., Languet B., Desmettre P. Field use of a vaccinia-rabies recombinant vaccine for the control of sylvatic rabies in Europe and North America. Rev. Sci. Technol. 1996, 15:947-970.
14. Bruyère V., Vuillaume P., Cliquet F., Aubert M. Oral rabies vaccination of foxes with one or two delayed distributions of SAG2 baits during the spring. Vet. Res. 2000, 31:339-345.
15. Butler L. Population sizes and colour phase genetics of the coloured fox in Quebec. Can. J. Zool. 1951, 29:24-41.
16. Centers for Disease Control and Prevention Translocation of coyote rabies-Florida, 1994. Morbid. Mortal. Weekly Rep. 1995, 44:580-587.
17. Centers for Disease Control and Prevention Notice to readers: Public Health Service recommendations for the use of vaccines manufactured with bovine-derived materials. Morbid. Mortal. Weekly Rep. 2000, 49:1137-1138.
18. Centers for Disease Control and Prevention Compendium of animal rabies prevention and control, 2001. National Association of State Public Health Veterinarians, Inc. Morbid. Mortal. Weekly Rep. 2001, 50(RR-08):1-9.
19. Centers for Disease Control Vaccinia (smallpox) vaccine recommendations of the Advisory Committee on Immunization Practices. Morbid. Mortal. Weekly Rep. 2001, 50(RR-10):1-25.
20. Charlton K.M. Rabies: Spongiform lesions in the brain. Acta Neuropathol. (Berl.) 1984, 63:198-202.
21. Charlton K.M., Webster W.A., Casey G.A., Rupprecht C.E. Skunk rabies. Rev. Infect. Dis. 1988, 10(Suppl. 4):S626-S628.
22. Charlton K.M., Artois M., Prevec L., Campbell J.B., Casey G.A., Wandeler A.I., Armstrong J. Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine. Arch. Virol. 1992, 123:169-179.
23. Childs J.E., Curns A.T., Dey M.E., Real L.A., Feinstein L., Bjørnstad O.N., Krebs J.W. Predicting the local dynamics of epizootic rabies among raccoons in the United States. Proc. Natl. Acad. Sci. USA 2000, 97:13666-13671.
24. Coyne M.J., Smith G., McAllister F.E. Mathematical model for the population biology of rabies in raccoons in the mid-Atlantic states. Am. J. Vet. Res. 1989, 12:2148-2154.
25. Creekmore T.E., Linhart S.B., Corn J.L., Whitney M.D., Snyder B.D., Nettles V.F. Field evaluation of baits and baiting strategies for delivering oral vaccine to mongooses in Antigua, West Indies. J. Wildlife Dis. 1994, 30:497-505.
26. Ellenton J.A., Johnston D.H. Oral biomarkers of calciferous tissues in carnivores. Transactions of the 1975 Eastern Coyote Workshop 1979, 60-67.
27. Farry S.C., Henke S.E., Beasom S.L., Fearneyhough M.G. Efficacy of bait distributional strategies to deliver canine rabies vaccines to coyotess in southern Texas. J. Wildlife Dis. 1998, 34:23-32.
28. Fearneyhough M.G., Wilson P.J., Clark K.A., Smith D.R., Johnston D.H., Hicks B.N., Moore G.M. Results of an oral rabies vaccination program for coyotes. J. Am. Vet. Med. Assoc. 1998, 212:498-502.
29. Fekadu M., Shaddock J.H., Sumner J.W., Sanderlin D.W., Knight J.C., Esposito J.J., Baer G.M. Oral vaccination of skunks with raccoon poxvirus recombinants expressing the rabies glycoprotein or the nucleoprotein. J. Wildlife Dis. 1991, 27:681-684.
30. Finley D. Mad Dogs: New Rabies Plague 1998, Texas A&M University Press, College Station, TX.
31. Follmann E.H., Ritter D.G., Baer G.M. Evaluation of the safety of two attenuated oral rabies vaccines, SAG1 and SAG2, in six Arctic mammals. Vaccine 1996, 14:270-273.
32. Hammami S., Schumacher C., Cliquet F., Tlatli A., Aubert A., Aubert M. Vaccination of Tunisian dogs with the lyophilised SAG2 oral rabies vaccine incorporated into the DBL2 dog bait. Vet. Res. 1999, 130:607-613.
33. Hanlon C.L., Hayes D.E., Damir A.N., Snyder D.E., Jenkins S.R., Hable C.P., Rupprecht C.E. Proposed field evaluation of a rabies recombinant vaccine for raccoons (Procyon lotor): Site selection, target species characteristics, and placebo baiting trials. J. Wildlife Dis. 1989, 25:555-567.
34. Hanlon C.A., Buchanan J.R., Nelson E., Niu H.S., Diehl D., Rupprecht C.E. A vaccinia-vectored rabies vaccine field trial: Ante- and post-moretem biomarkers. Rev. Sci. Technol. 1993, 12:99-107.
35. Hanlon C.A., Niezgoda M., Hamir A.N., Schumacher C., Koprowski H., Rupprecht C.E. First North American field release of a vaccinia-rabies glycoprotein recombinant virus. J. Wildlife Dis. 1998, 34:228-239.
36. Hanlon C.A., Childs J.E., Nettles V.F. Recommendations of a national working group on prevention and control of rabies in the United States: III. Rabies in wildife. J. Am. Vet. Med. Assoc. 1999, 215:1612-1619. National Working Group on Rabies Prevention and Control.
37. Hauschildt P., Tinline R.R., Ball D.G.A. Outfoxing rabies in Ontario. GPS World 2001, 34-39. May 2001.
38. Hill R.E., Beran G.W., Clark W.R. Demonstration of rabies virus-specific antibody in the sera of free-ranging Iowa raccoons (Procyon lotor). J. Wildlife Dis. 1992, 28:377-385.
39. Hu L., Ngichabe C., Trimarchi C.V., Esposito J.J., Scott F.W. Raccoon poxvirus live recombinant feline panleukopenia virus VP2 and rabies virus glycoprotein bivalent vaccine. Vaccine 1997, 15:1466-1472.
40. Jackson A.C. The fatal illness of the Fourth Duke of Richmond in Canada: Rabies. Ann. R. Coll. Phys. Surg. Can. 1994, 27:40-41.
41. Jenkins S.R., Perry B.D., Winkler W.G. Ecology and epidemiology of raccoon rabies. Rev. Infect. Dis. 1988, 10(Suppl. 4):S620-S625.
42. Johnston D.H., Beauregard M. Rabies epidemiology in Ontario. Bull. Wildlife Dis. Assoc. 1969, 5:357-370.
43. Johnston D.H. The Principles of Wild Carnivore Baiting with Oral Rabies Vaccines WHO Consultation on Oral Vaccination of Foxes, Frankfurt am Main, Item 5, Document 7 1975, WHO, Geneva.
44. Johnston D.H., Voigt D.R. A baiting system for the oral rabies vaccination of wild foxes and skunks. Comp. Immunol. Microbiol. Infect. Dis. 1982, 5:185-186.
45. Johnston D.H., Fearneyhough M.G., Hicks B.N., Moore G.M. L'influence de l'âge de la population sur le succès apparent des essais de vaccination orale antirabique utilisant de la tétracycline comme marqueur. Colloque International sur la Rage 1997, 5-12. Insetitut Pasteur, Paris.
46. Johnston D.H., Joachim D.G., Bachmann P., Kardong K.V., Stewart R.E.A., Dix L.M., Strickland M.A., Watt I.D. Aging furbearers using tooth structure and biomarkers. Wild Furbearer Management and Conservation in North America 1999, 228-243. Ontario Fur Managers Federation, Sault Ste Marie, Ontario. M. Novak, J.A. Baker, M.E. Obbard, B. Malloch (Eds.).
47. Kreeeer T.J. Contraception in Wildlife Management, Technical Bulletin No. 1853 1997, U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Washington.
48. Kreindel S.M., McGuill M., Meltzer M., Rupprecht C., DeMaria A. The cost of rabies postexposure prophylaxis: One state's experience. Public Health Rep. 1998, 113:247-251.
49. Lawson K.F., Chiu H., Crosgrey S.J., Matson M., Casey G.A., Campbell J.B. Duration of immunity in foxes vaccinated orally with ERA vaccine in a bait. Can. J. Vet. Res. 1997, 61:39-42.
50. Lawson K.F., Bachmann P. Stability of attenuated live virus rabies vaccine in baits targeted to wild foxes under operational conditions. Can. Vet. J. 2001, 42:368-374.
51. Lin C.C., Johnston D.H., Ramsden R.O. Polymorphism and quinacrine fluorescence karotypes of red fox (Vulpes vulpes). Can. J. Genet. Cytol. 1972, 14:573-580.
52. Linhart S.B., Kennelly J.J. Fluorescent bone labeling of coyotes with demethylchlortetracycline. J. Wildlife Manag. 1967, 31:317-321.
53. Linhart S.B., Kappeler A., Windberg L. A review of baits and bait delivery systems for free-raning carnivores and ungulates. Technical Bulletin No. 1853 1997, 69-132. U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Washington. T.J. Kreeger (Ed.).
54. Lloyd H.G. The Red Fox 1980, B.T. Batsford, London.
55. MacInnes C.D., Johnston D.H. Ontario Fish and Wildlife Review 1975, 14:17-20.
56. MacInnes C.D., Johnston D.H., Bachmann P., Pond B.A., Fielding C.A., Nunan C.P., Ayers N.R., Voigt D.R., Lawson K.F., Tinline R.R. Design considerations for largescale aerial distribution of rabies vaccine-baits in Ontario. Wildlife Rabies Control 1992, 160-167. Wells Medical, Kent. England. K. Bögel, F.-X. Meslin, M. Kaplan (Eds.).
57. MacInnes C.D., Smith S.M., Tinline R.R., Ayers N.R., Bachmann P., Ball D.G.A., Caulder L.A., Crosgrery S.J., Fielding C., Hauschildt P., Honig J.M., Johnston D.H., Lawson K.F., Nunan C.P., Pedde M.A., Pond B., Stewart R.B., Voigt D.R. Elimination of rabies from red foxes in eastern Ontario. J. Wildlife Dis. 2001, 37:119-132.
58. Masson E., Aubert M.F., Rotivel Y. Human contamination by baits for vaccinating foxes against rabies in France. Santé Publique 1997, 9:297-313.
59. Masson E., Bruyère-Masson V., Vuillaume P., Lemoyne S., Aubert M. Rabies oral vaccination of foxes during the summer with the VRG vaccine bait. Vet. Res. 1999, 30:595-605.
60. Matter H.C., Schumacher C.L., Kharmachi H., Hammami S., Tlatli A., Jemli J., Mrabet L., Meslin F.-X., Aubert M.F., Neuenschwander B.E., Hicheri K.E. Field evaluation of two bait delivery systems for the oral immunization of dogs against rabies in Tunisia. Vaccine 1998, 16:657-665.
61. McGuill M.W., Kreindel S.M., DeMaria A., Rupprecht C.E. Knowledge and attitudes of residents in two areas of Massachusetts about rabies and an oral vaccination program in wildlife. J. Am. Vet. Med. Assoc. 1997, 211:305-309.
62. Meltzer M.I. Assessing the cost and benefits of an oral vaccine for raccoon rabies: A possible model. Emerg. Infect. Dis. 1996, 2:343-349.
63. Merial, Inc. Control of Raccoon Rabies Using Merial's Raboral V-RG Vaccine 1999, Merial Inc., Athens, GA.
64. Messenger S.L., Rupprecht C.E., Smith J.S. Bats, emerging virus infections, and the rabies paradigm. Bat Ecology 2002, University of Chicago Press, Chicago. T.H. Kunz, M.B. Fenton (Eds.).
65. Moore K.L. The sex chromatin of various animals. The Sex Chromatin 1966, 23-27. W. B. Saunders, Philadelphia. K.L. Moore (Ed.).
66. Müller T.F., Stöhr K., Teuffert J., Stöhr P. Erfahrungen mit der Flügzeugausbringung von Ködern zur oralen Immunisierung der Füchse gegen Tollwut in Ostdeutschland. Dtsch. Tierarztl Wochenschr. 1993, 100:203-207.
67. Müller T.F., Schuster P., Vos A.C., Selhorst T., Wenzel U.D., Neubert A.M. Effect of maternal immunity on the immune response of young foxes to oral vaccination with SAD B19. Am. J. Vet. Res. 2001, (in press).
68. Müller W.W. Where do we stand with oral vaccination of foxes against rabies in Europe?. Arch. Virol Suppl. 1997, 13:83-94.
69. Murray J.D., Stanley A.A., Brown D.L. On the spatial spread of rabies among foxes. Proc. R. Soc. Lond. [B] 1986, 229:111-150.
70. Nadin-Davis S.A., Huang W., Wandeler A.I. The design of strain-specific polymerase chain reactions for discrimination of the raccoon rabies virus strain from indigenous rabies viruses of Ontario. J. Virol. Method 1996, 57:1-14.
71. Nettles V.F., Shaddock J.H., Sikes R.K., Reyes C.R. Rabies in translocated raccoons. Am. J. Public Health 1979, 69:601-602.
72. Nunan C.P., MacInnes C.D., Bachmann P., Johnston D.H., Watt I.D. Background prevalence of tetracycline-like fluorescence in teeth of free ranging red foxes (Vulpes vulpes:), striped skunks (Mephitis mephitis) and raccoons (Procyon lotor) in Ontario, Canada. J. Wildlife Dis. 1994, 30:112-114.
73. Nunan C.P. Legalities, insurance and liabilities in rabies control programs: What rabies researchers should know (Abstract). 10th Annual Rabies in the Americas Meeting 1999.
74. Nyberg M., Kulonen K., Neuvonen E., Ek-Kommonen C., Nuorgam M., Westerling B. An epidemic of sylvatic rabies in Finland-Descriptive epidemiology and results of oral vaccination. Acta Vet. Stand. 1992, 33:43-57.
75. Olson C.A., Mitchell K.D., Werner P.A. Bait ingestion by free-ranging raccoons and nontarget species in an oral rabies vaccine field trial in Florida. J. Wildlife Dis. 2000, 36:734-743.
76. Perry B.D., Brooks R., Foggin C.M., Bleakley J., Johnston D.H., Hill F.W. A baiting system suitable for the delivery of oral rabies vaccine to dog populatioins in Zimbabwe. Vet. Rec. 1988, 123:76-79.
77. Robbins A.H., Borden M.D., Windmiller B.S., Niezgoda M., Marcus L.C., O'Brien S.M., Kreindel S.M., McGuill M.W., DeMaria A., Rupprecht C.E., Rowell S. Prevention of the spread of rabies to wildlife by oral vaccination of raccoons in Massachusetts. J. Am. Vet. Med. Assoc. 1998, 213:1407-1412.
78. Rosatte R.C., Gunson J.R. Presence of neutralizing antibodies to rabies virus in striped skunks from areas free of skunk rabies in Alberta. J. Wildlife Dis. 1984, 20:171-176.
79. Rosatte R.C., MacInnes C.D. Relocation of city raccoons. USDA Forest Service General Technical Report RM-171, Great Plains Agricultural Council Publication 127 1989, 87-92. A.J. Bjugstad, D.W. Uresk, R.H. Hamre (Eds.).
80. Rosatte R.C., Power M.J., MacInnes C.D. Trap-vaccinate-release and oral vaccination techniques for the control of rabies in foxes, skunks and raccoons in urban settings. Wildlife Rabies Control 1992, 175-179. Wells Medical, Royal Tunbridge Wells, Kent, England. K. Bögel, F.-X. Meslin, M. Kaplan (Eds.).
81. Rosatte R.C. Long distance movement by a coyote and a red fox in Ontario: Implications for disease-spread. Can. Field Nat. 2001, (in press).
82. Rosatte R.C., Donovan D., Allan M., Howes L., Silver A., Bennett K., MacInnes C., Davies C., Wandeler A., Radford B. Emergency response to raccoon rabies introduction in Ontario. J. Wildlife Dis, 2001, 37:265-279.
83. Roscoe D.E., Holste W.C., Sorhage F.E., Campbell C., Niezgoda M., Buchannan R., Diehl D., Niu H.S., Rupprecht C.E. Efficacy of an oral vaccinia-rabies glycoprotein recombinant vaccine in controlling epidemic raccoon rabies in New Jersey. J. Wildlife Dis. 1998, 34:752-763.
84. Rupprecht C.E., Wiktor T.J., Johnston D.H., Hamir A.N., Dietzschold B., Wunner W.H., Glickman L., Koprowski H. Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine. Proc. Natl. Acad. Sci. USA 1986, 83:7947-7950.
85. Rupprecht C.E., Smith J.S., Fekadu M., Childs J.E. The ascension of wildlife rabies: A cause for public health concern or intervention. Emerg. Infect. Dis. 1995, 1:107-114.
86. Selhorst T., Thulke H.H., Muller T. Threshold analysis of cost-efficient oral vaccination strategies against rabies in fox populations. Proc. Soc. Vet. Epidemiol. Prevent. Med. 2000, 2000:71-84.
87. Smith G.C., Harris S. Rabies in urban foxes in Britain: The use of a spatial stochastic simulation model to examine the pattern of spread and evaluate the efficacy of different control regimes. Philos. Trans. R. Soc. Lond. [B] 1991, 334:459-479.
88. Smith K.A., Krogwold R., Smith F., Hale R., Collart M., Craig C. The Ohio ORV Program (Abstract). 10th Annual Rabies in the Americas Meeting 1999.
89. Steck F., Wandeler A., Bichsel P., Capt S., Schneider L. Oral immunisation of foxes against rabies. A field study. Zentralbl. Veterinärmed. 1982, 29:372-396.
90. Stöhr K., Meslin F.-X. Progress and setbacks in the oral immunisation of foxes against rabies in Europe. Vet. Rec. 1996, 13:32-35.
91. Suppo C., Nauline J., Langlais M., Artois M. A modeling approach to vaccination and contraception programmes for rabies control in fox populations. Proc. R. Soc. Lond. [B] 2000, 267:1575-1582.
92. Svrcek S., Durove A., Ondrejka R., Zavadova J., Suliova J., Benisek Z., Vrtiak O.J., Feketeova J., Madar M. Immunogenic and antigenic activity of an experimental oral rabies vacine prepared from the strain Vnukovo-32/107. Vet. Med. (Praha) 1995, 40:87-96.
93. Thulke H., Tischendorf L., Staubach C., Shelhorst T., Jeltsch F., Goretzki J., Müller T., Schluter H., Wissel C. The spatiotemporal dynamics of a post-vaccination resurgence of rabies in foxes and emergency vaccination planning. Prevent. Vet. Med. 2000, 47:1-21.
94. Tims T., Briggs D.J., Davis R.D., Moore S.M., Xiang Z., Ertl H.C., Fu Z.F. Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies. Vaccine 2000, 18:2804-2807.
95. Tinline R.R. Persistance of rabies in wildlife. Rabies 1988, 301-322. Kluwer Academic, Boston. J.B. Campbell, K.M. Charlton (Eds.).
96. Tinline R.R., Ball D.G.A., Nunan C.P., Venodrai T. The impact of flight line spacing and baiting density on the uptake of oral rabies vaccine via aerial distribution (Abstract). 10th Annual Rabies in the Americas Meeting 1999.
97. Tischendorf L., Thulke H., Staubach C., Müller M.S., Jeltsch F., Goretzki J., Shelhorst T., Muller T., Schlüter H., Wissel C. Chance and risk of controlling rabies in large-scale and long-term immunized fox populations. Proc. R. Soc. Lond. [B] 1998, 265:839-846.
98. Uhaa I.J., Dato V.M., Sorhage F.E., Beckley J.W., Roscoe D.E., Gorsky R.D., Fishbein D.B. Benefits and costs of using an orally absorbed vaccine to control rabies in raccoons. J. Am. Vet. Med. Assoc. 1992, 15:1873-1882.
99. Voigt D.R., Tinline R.R., Broekhoven L.H. Spatial simulation model for rabies control. Population Dynamics of Rabies in Wildlife 1985, 311-349. Academic Press, London. P.J. Bacon (Ed.).
100. Vrzal V., Matouch O. Annual testing of immunity in foxes after oral rabies immunization. Vet. Med. (Praha) 1996, 4:107-111.
101. Wandeler A.I., Pfotenhauer P., Stocker C. Uber die Verwendung von Ködern zu biologischen Untersuchungen an Füchsen. Rev. Suisse Zool. 1975, 82:335-348.
102. Wandeler A.I., Nadin-Davis S.A., Tinline R.R., Rupprecht C.E. Rabies epizootiology: An ecological and evolutionary perspective. Curr. Top. Microbiol. Immunol. 1994, 186:297-324.
103. Wandeler A.I. Oral immunization against rabies: afterthoughts and foresight. Schweiz. Arch. Tierheilk. 2000, 142:455-462.
104. Windberg L.A. Management implications of coyote spacing patterns in southern Texas. J. Wildlife Manag. 1988, 52:632-640.
105. Winkler W.G. A review of the development of the oral vaccination technique for immunizing wildlife against rabies. Wildlife Rabies Control 1992, 82-96. Wells Medical, Royal Tunbridge Wells, Kent, England. K. Bögel, F.-X. Meslin, M. Kaplan (Eds.).
106. World Health Organization WHO Expert Committe on Rabies, Fifth Report. WHO Technical Report Series 321 1966, WHO, Geneva.